Menggagas Pengaruh NSAID terhadap Keberhasilan Penyembuhan dari Asam Urat (Gout) dan Covid-19
Keywords:
covid-19, gout, NSAIDAbstract
NSAID (Non-Steroid Anti-Inflamatory drugs) adalah suatu golongan obat yang memiliki khasiat sebagai Analgetik (pereda nyeri),Antipiretik ( penurun panas) dan Anti-inflamasi ( anti radang) dan merupakan obat yang paling banyak diresepkan dan merupakan obat pilihan pertama nyeri inflamasi lainnya karena dapat mengurangi nyeri bersadasarkan gejala.terdapat beberapa jenis NSAID yang sudah populer di telinga masyarakat diantaranya Ibuprofen, asam mefenamat,parasetamol dan endometasin.setiap jenis NSAID memberi efek samping dan keuntungan.efek NSAID bisa dikaitkan dengan mekanisme aksi dengan menggunakan NSAID untuk pasien GOUT dan COVID harus di perhatikan .Arthritis gout merupakan salah satu penyakit metabolik yang di tandai dengan meningkatnya konsentrasi asam urat (hiperuresemia) sedangkan COVID-19 adalah penyakit yang disebabkan oleh turunan coronavirus baru yang ditularkan melalui kontak langsung dengan percikan dari saluran napas orang yang terinfeksi (yang keluar melalui batuk dan bersin).
References
Acute use of NSAIDs for people with or at risk of COVID-19: rapid evidence summary.hospitalhealthcare.2020.Availablefrom:https://hospitalhealthcare.com/covid-19/acute-use-of-nsaids-for-people-with-or-at-risk-of-covid-19-rapid-evidence-summary/
Carter MA., Gout dalam Patofosiologi: Konsep Klinis Proses-proses Penyakit, Jakarta, EGC, 2006. 1402-1405 p.
CHPA Statement Regarding Recent Observational Studies of NSAIDs and COVID-19. chpa. 2020. Available from: https://www.chpa.org/COVID-NSAID.aspx
Coburn BW, Mikuls TR. Treatment Options for Acute Gout. Fed Pract. 2016 January;33(1):35-40 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366613/
Conway N, Schwartz S. Diagnosis and management of acute gout. Medicine and health, Rhode Island. 2009.
Food & Drug F. FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. Food and Drug Administration. 2020.
Giollo A, Adami G, Gatti D, Idolazzi L, Rossini M. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID). Annals of the Rheumatic Diseases. 2020.
GNS Staff. WHO: No Evidence of Bad Outcomes From NSAID Use in COVID-19 Patients. Generalsurgerynews. 2020. Available from: https://www.generalsurgerynews.com/COVID-19/Article/04-20/WHO-No-Evidence-of-Bad-Outcomes-From-NSAID-Use-in-COVID-19-Patients/58140
Indonesian Journal of Dentistry 2008; 15 (3):200-204 http//wwww.fkg.ui.edu
International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 – 6718, ISSN (Print): 2319 – 670X http//www.ijpsi.org Volume 3 Issue 2‖ February 2013 ‖ PP.28-33.
Khanna D, Khanna PP, Fitzgerald JD. 2012 American College of Rheumatology Guidelines for Management of Gout Part II: Therapy and Antiinflammatory Prophylaxis of Acute Gouty Arthritis. Arthritis Care Res (Hoboken). 2012 October;64(10):1447-61 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662546/
Khanna PP, Gladue HS, Singh MK, FitzGerald JD, Bae S, Prakash S, et al. Treatment of acute gout: A systematic review. Seminars in Arthritis and Rheumatism. 2014.
Kharisma Y. Tinjauan Umum Penyakit Hiperurisemia dan Gout. Fakultas Kedokteran Universitas Islam Bandung. 2017:31-3 http://repository.unisba.ac.id/bitstream/handle/123456789/8317/kharisma_mak_tinjauanpenyakit_peningkatan_kadar_asam_urat_2017_sv.pdf?sequence=1&isAllowed=y
Kurniawati HF. Gambaran Penggunaan Internet Dalam Pencarian Informasi Tentang HIV dan AIDS pada Remaja. J Kebidanan. 2019;
Little P. Non-steroidal anti-inflammatory drugs and covid-19. The BMJ. 2020.
Maratu Soleha, Ani Isnawati, Nyoman Fitri, Rosa Adelina, Hamim Tsalis Soblia, Winarsih. Profil Penggunaan Obat Antiinflamasi Nonsteroid di Indonesia. Jurnal Kefarmasian Indonesia. Vol.8 No.2-Agustus 2018:109-117.
Motola D, Vaccheri A, Silvani MC, Poluzzi E, Bottoni A, De Ponti F, et al. Pattern of NSAID use in the Italian general population: A questionnaire-based survey. European Journal of Clinical Pharmacology. 2004.
NSAIDs. nhs. 2019. Availabe from: https://www.nhs.uk/conditions/nsaids/
Qaseem A, Harris RP, Forciea MA, Denberg TD, Barry MJ, Boyd C, et al. Management of acute and recurrent gout: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;
Russell B, Moss C, Rigg A, Van Hemelrijck M. COVID-19 and treatment with NSAIDs and corticosteroids: Should we be limiting their use in the clinical setting? Ecancermedicalscience. 2020;
Siti Nadhira. 2018. Evaluasi Penggunaan Obat NSAID (Non-Steroidal Anti Inflammatory Drug) Pada Pasien Osteoarthritis Rawat Jalan di RS TNI AD Robert Wolter Mongisidi Manado [skripsi]. Malang (ID) : Universitas Islam Negeri Maulana Malik Ibrahim Malang.
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, et al. Coronavirus Disease 2019: Tinjauan Literatur Terkini. J Penyakit Dalam Indones. 2020; Purwaningsih T., Faktor-faktor Risiko Hiperurisemia,Tesis, 2009
Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971; Sala A., Folco G. Actual Role of Prostaglandin in inflammation, in Drug invest, 1999. 4-9
Widyanto FW. Arthritis Gout dan Perkembangannya. Saintika Med. 2017; Fajrani. Indonesia Journal of dentisry 2008; 15 (3):200-204 http//www.fkg.ui.edu.2008
Widiyanto, A., Murti, B., & Soemanto, R. B. (2018). Multilevel analysis on the Socio-Cultural, lifestyle factors, and school environment on the risk of overweight in adolescents, Karanganyar district, central Java. Journal of Epidemiology and Public Health, 3(1), 94-104.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Jurnal Ilmiah Permas: Jurnal Ilmiah STIKES Kendal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
